Compare ANSC & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANSC | LYEL |
|---|---|---|
| Founded | 2021 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.0M | 548.9M |
| IPO Year | N/A | 2021 |
| Metric | ANSC | LYEL |
|---|---|---|
| Price | $11.22 | $23.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 42.4K | ★ 89.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $61,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $55.07 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.57 | $0.39 |
| 52 Week High | $11.24 | $45.00 |
| Indicator | ANSC | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 43.89 |
| Support Level | N/A | $21.72 |
| Resistance Level | N/A | $27.30 |
| Average True Range (ATR) | 0.00 | 2.60 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 0.00 | 36.63 |
Agriculture & Natural Solutions Acquisition Corp is a blank check company.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.